Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FOPO nets $46.1mm for Tetraphase

Executive Summary

Eight months after completing its IPO, Tetraphase Pharmaceuticals Inc. netted $46.1mm through the follow-on public sale of 4.9mm common shares (including the overallotment) at $10 each. The company originally planned to offer 3.3mm shares.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies